VOYA Investment Management
MNTA

VOYA Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

VOYA Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-425,465
Closed -$14.2M – 2546
2020
Q2 		$14.2M Buy
425,465
+127,724
+43% +$4.07M 0.03% 420
2020
Q1 		$8.1M Sell
297,741
-117,159
-28% -$3.26M 0.02% 556
2019
Q4 		$8.19M Buy
414,900
+374,841
+936% +$5.99M 0.02% 675
2019
Q3 		$519K Hold
40,059
– – ﹤0.01% 1737
2019
Q2 		$499K Buy
40,059
+1,156
+3% +$15.3K ﹤0.01% 1779
2019
Q1 		$565K Buy
38,903
+6,359
+20% +$81.2K ﹤0.01% 1704
2018
Q4 		$359K Buy
32,544
+1,079
+3% +$15K ﹤0.01% 1927
2018
Q3 		$828K Hold
31,465
– – ﹤0.01% 1524
2018
Q2 		$643K Sell
31,465
-1,468
-4% -$31.5K ﹤0.01% 1643
2018
Q1 		$598K Sell
32,933
-23,512
-42% -$392K ﹤0.01% 1689
2017
Q4 		$787K Sell
56,445
-13,379
-19% -$181K ﹤0.01% 1570
2017
Q3 		$1.29M Sell
69,824
-22,385
-24% -$374K ﹤0.01% 1254
2017
Q2 		$1.56M Sell
92,209
-30,797
-25% -$469K ﹤0.01% 1142
2017
Q1 		$1.64M Buy
123,006
+96,056
+356% +$1.5M ﹤0.01% 1105
2016
Q4 		$406K Hold
26,950
– – ﹤0.01% 1868
2016
Q3 		$315 Hold
26,950
– – ﹤0.01% 2013
2016
Q2 		$291K Hold
26,950
– – ﹤0.01% 2042
2016
Q1 		$249K Hold
26,950
– – ﹤0.01% 2111
2015
Q4 		$400K Sell
26,950
-223,795
-89% -$3.74M ﹤0.01% 1865
2015
Q3 		$4.12M Sell
250,745
-161,306
-39% -$3.3M 0.01% 818
2015
Q2 		$9.4M Sell
412,051
-124,029
-23% -$2.47M 0.02% 613
2015
Q1 		$8.15M Buy
536,080
+181,200
+51% +$2.35M 0.02% 659
2014
Q4 		$4.27M Hold
354,880
– – 0.01% 843
2014
Q3 		$4.02M Sell
354,880
-401
-0.1% -$4.57K 0.01% 853
2014
Q2 		$4.29M Sell
355,281
-7,300
-2% -$86.2K 0.01% 865
2014
Q1 		$4.22M Sell
362,581
-17,980
-5% -$304K 0.01% 845
2013
Q4 		$6.73M Sell
380,561
-2,500
-0.7% -$42K 0.02% 701
2013
Q3 		$5.51M Sell
383,061
-35,749
-9% -$547K 0.01% 749
2013
Q2 		$6.31M Buy
+418,810
New +$5.53M 0.02% 695

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

VOYA Investment Management's MNTA Position: Q3 2020 in Review

VOYA Investment Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 425,465 shares — an estimated $14.2M sold.

VOYA Investment Management first reported a position in MNTA in Q2 2013 and held it in 29 quarters. The position peaked at $14.2M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • VOYA Investment Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • VOYA Investment Management sold 425,465 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $14.2M.
  • VOYA Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 29 quarters.
  • VOYA Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $14.2M in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on VOYA Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.